<DOC>
	<DOCNO>NCT00567411</DOCNO>
	<brief_summary>The purpose study compare safety efficacy two drop use low eye pressure give prior glaucoma laser procedure .</brief_summary>
	<brief_title>Comparison Alpha-2 Agonists Prevention Intraocular Pressure Elevation After Selective Laser Trabeculoplasty</brief_title>
	<detailed_description>This prospective randomize double blind trial patient undergo selective laser trabeculoplasty primary open angle glaucoma ocular hypertension . Enrolled patient randomize receive one drop brimonidine 0.1 % one eye one drop apraclonidine 0.5 % fellow eye . The trabecular meshwork eye enrol patient treat 360 degree sit . Intraocular pressure measure eye one hour apply study medication one hour one week laser surgery .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Apraclonidine</mesh_term>
	<criteria>male female , least 18 year age Open Angle Glaucoma inadequate intraocular pressure ( IOP ) control evidence progression ( base optic nerve head appearance and/or visual field change ) despite current medical therapy Ocular Hypertension require lower IOP ability understand provide inform consent participate study willingness follow study instruction likely complete require visit inability understand provide inform consent participate study inability/unwillingness follow study instruction complete require visit Documented allergy either brimonidine iopidine Angle Closure Glaucoma Congenital/Juvenile Glaucoma Neovascular Glaucoma Active uveitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Laser</keyword>
	<keyword>laser trabeculoplasty</keyword>
	<keyword>selective laser trabeculoplasty</keyword>
	<keyword>intraocular pressure</keyword>
</DOC>